Clinical Trial Update: Low-dose Radiotherapy in iNHL [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update investigating low-dose radiotherapy for indolent lymphoma is reported, with unclear status and sponsor information.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Indolent Lymphoma

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Indolent Lymphoma, Low-dose Radiotherapy | Phase 2 | Status: UNKNOWN